Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Corporate gatekeepers and big tech monopolists are making it more difficult than ever for independent media to survive. Please chip in today.

A woman wearing a mask walks by Gilead Sciences headquarters sign in Foster City, California on April 30, 2020. (Photo: Josh Edelson/AFP via Getty Images)

34 State Attorneys General Urge Trump to End 'Outrageous' Gilead Monopoly on Covid-19 Drug

"This is not the time for any company to extract large corporate profits from uninsured and underinsured Americans."

Jake Johnson

Warning of "dangerously low and insufficient" supply projections, a bipartisan coalition of nearly three dozen state attorneys general is urging the Trump administration to end pharmaceutical giant Gilead's monopoly control over Covid-19 treatment remdesivir by authorizing generic production of the drug, which was developed with the support of at least $70 million in taxpayer funding.

"Taxpayers funded remdesivir's development from the drug's early days. Generic competition would help expand supply and ensure reasonable pricing. Remdesivir should be in the public domain."
—Peter Maybarduk, Public Citizen

"Now more than ever, the American public needs the support of the federal government in helping them afford Covid-19-related treatment," the coalition led by California's Democratic AG Xavier Becerra and Louisiana's Republican AG Jeff Landry wrote in a letter (pdf) Tuesday to Health and Human Services Secretary Alex Azar and National Institutes of Health director Dr. Francis Collins.

"This is not the time for any company to extract large corporate profits from uninsured and underinsured Americans—nor can we allow the individual market priorities and weaknesses of one company to determine the fates of hundreds of thousands of people," the letter reads. "Gilead should not profit from the pandemic and it should be pushed to do more to help more people."

The attorneys general are demanding that the Trump administration immediately exercise its authority under the Bayh-Dole Act, a 1980 law giving the federal government the power to license third-party manufacturers to produce a drug if the patent-holder fails to make the treatment available on "reasonable terms."

"At a minimum," the attorneys general wrote, "we ask that you support states by assigning to states the ability to use the march-in rights under this law to achieve the same purposes."

As Common Dreams reported in June, Gilead is charging U.S. hospitals around $3,120 per privately insured patient for a treatment course of remdesivir—a price tag the attorneys general slammed as "outrageous and unconscionable." Consumer advocacy group Public Citizen estimates that Gilead could have priced remdesivir at $1 per day and still turned a reasonable profit.

"It is unfortunate that Gilead has chosen to place its profit margins over the interests of Americans suffering in this pandemic," the coalition of attorneys general wrote. "Record unemployment and ongoing financial troubles will prevent many Americans from paying for remdesivir. Even for the insured, Gilead’s excessive pricing makes copayments and out-of-pocket expenses cost-prohibitive."

Despite the massive infusion of public funding for remdesivir, the attorneys general warned that Gilead remains "unable to guarantee a supply of remdesivir sufficient to alleviate the health and safety needs of the country amid the pandemic."

"Gilead's production projection remains dangerously low and insufficient to handle the current domestic demands, let alone future demands for the antiviral drug," reads the letter, which was signed by attorneys general from Minnesota, Ohio, Utah, Nebraska, and dozens of other states.

Peter Maybarduk, director of the Access to Medicines program at Public Citizen, echoed the demand for an end to Gilead's monopoly on remdesivir production in a statement Tuesday.

"Gilead's monopoly control of remdesivir leads to shortages and rationing and keeps prices high," said Maybarduk. "Taxpayers funded remdesivir's development from the drug's early days. Generic competition would help expand supply and ensure reasonable pricing. The federal government—we the people, that is—appears to co-own remdesivir's core patents. Remdesivir should be in the public domain."

"While remdesivir is no kind of pandemic panacea," Maybarduk added, "hospitals should be able to rely on a robust, affordable supply and make choices according to medical need."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

As Evisceration of Roe Looms, Poll Finds Support for Abortion Rights at New High

The findings come on the heels of nationwide marches in defense of reproductive rights.

Andrea Germanos ·


Kagan Pens Scathing Dissent as Supreme Court Kills Another Campaign Finance Rule

"In allowing those payments to go forward unrestrained, today's decision can only bring this country's political system into further disrepute," wrote Justice Elena Kagan.

Jake Johnson ·


Jailed Palestinian Lawyer Implores ICC to Probe Israeli 'Crimes Against Humanity' in East Jerusalem

"We urge the ICC prosecutor to take active and concrete investigative steps in order to break the cycle of impunity for perpetrators of war crimes and crimes against humanity committed in Palestine."

Brett Wilkins ·


'Oil Fuels War': Greenpeace Activists Block Tanker Carrying Russian Diesel to UK

"To stand up to Putin, bring bills down, and tackle climate change, the prime minister must get us off fossil fuels as fast as possible."

Kenny Stancil ·


Bezos Praises Manchin for Blocking Biden's Corporate Tax Hike

"Biden's plan was to make billionaires and corporations pay their fair share in taxes, and use that money to help families," said one critic. "Of course a billionaire owner of a $1.1 trillion corporation doesn't like that."

Julia Conley ·

Common Dreams Logo